Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies
Scarcity of labeled data limits development of deep learning biomarkers in oncology. We develop a two-stage AI model predicting pathological complete response (pCR) to neoadjuvant therapy in breast cancer. The first stage learns the transcriptome from histopathology using 8,742 patients across 32 cancer types, corroborated by pathologist review and spatial agreement with measured expression. This…
We haven't written up this one. arXiv cs.AI has the full story — the link below goes straight to it.
